Loading...
XSES
8K7
Market cap52mUSD
Jul 16, Last price  
0.11SGD
1D
0.00%
1Q
6.93%
Jan 2017
13.68%
IPO
47.27%
Name

UG Healthcare Corporation Ltd

Chart & Performance

D1W1MN
P/E
—
P/S
0.58
EPS
—
Div Yield, %
—
Shrs. gr., 5y
1.47%
Rev. gr., 5y
4.67%
Revenues
115m
+13.91%
49,009,00055,740,00058,823,00065,239,00078,060,00091,712,000144,209,000338,401,000232,598,000101,133,000115,205,000
Net income
-6m
L-70.79%
4,900,0003,164,0005,450,0002,444,0004,335,0002,507,00013,402,000118,765,00036,795,000-20,734,000-6,056,000
CFO
-18m
L-53.62%
1,927,0001,983,000-1,405,000-7,105,000-402,000-6,367,00010,989,00081,162,00053,950,000-39,142,000-18,156,000
Dividend
Nov 17, 20220.0032 SGD/sh

Profile

UG Healthcare Corporation Limited, an investment holding company, manufactures and sells disposable gloves. It operates through three segments: Latex Examination Gloves, Nitrile Examination Gloves, and Other Ancillary Products. The company offers latex examination gloves that comprise single chlorinated and double chlorinated polymer coated gloves, as well as nitrile examination gloves. It also distributes ancillary products, including surgical gloves, vinyl and cleanroom disposable gloves, face masks, and other medical disposables, as well as shoe covers and other related products; and provides business and management consultancy services. The company's products are used in healthcare, food and beverage, industrial, high technology manufacturing, automotive, research and development, and beauty sectors. It serves customers under the Unigloves brand name in Malaysia, Europe, North America, South America, Africa, and rest of Asia. The company was founded in 1989 and is based in Singapore.
URL
https://www.ughealthcarecorporation.com/
IPO date
Dec 08, 2014
Employees
1,076
Domiciled in
MY
Incorporated in
SG

Valuation

Title
SGD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑06
Income
Revenues
115,205
13.91%
101,133
-56.52%
Cost of revenue
121,833
126,252
Unusual Expense (Income)
NOPBT
(6,628)
(25,119)
NOPBT Margin
Operating Taxes
(308)
(1,398)
Tax Rate
NOPAT
(6,320)
(23,721)
Net income
(6,056)
-70.79%
(20,734)
-156.35%
Dividends
(3,992)
Dividend yield
4.44%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
18,415
16,719
Long-term debt
26,183
15,003
Deferred revenue
Other long-term liabilities
Net debt
15,213
(37,084)
Cash flow
Cash from operating activities
(18,156)
(39,142)
CAPEX
(2,553)
(8,029)
Cash from investing activities
(22,732)
(8,029)
Cash from financing activities
8,362
8,698
FCF
(20,832)
(16,651)
Balance
Cash
27,998
61,745
Long term investments
1,387
7,061
Excess cash
23,625
63,749
Stockholders' equity
264,051
181,190
Invested Capital
181,371
146,913
ROIC
ROCE
EV
Common stock shares outstanding
623,826
623,826
Price
0.12
-16.67%
0.14
-34.55%
Market cap
74,859
-16.67%
89,831
-34.16%
EV
119,779
53,093
EBITDA
(2,756)
(21,645)
EV/EBITDA
Interest
1,282
915
Interest/NOPBT